Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patients

View ORCID ProfileThierry Prazuck, View ORCID ProfileRaphael Serreau, Aurelie Theillay, Sandra Pallay, Daniela Pires-Roteia, Fanny Prazuck, Fabien Lesne
doi: https://doi.org/10.1101/2022.09.29.22280448
Thierry Prazuck
1Service des maladies infectieuses, CHR Orleans, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thierry Prazuck
  • For correspondence: thierry.prazuck@chr-orleans.fr
Raphael Serreau
2PsycoMADD, CHU Paul Brousse, APHP, Univeristé Paris Saclay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raphael Serreau
Aurelie Theillay
1Service des maladies infectieuses, CHR Orleans, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Pallay
1Service des maladies infectieuses, CHR Orleans, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela Pires-Roteia
1Service des maladies infectieuses, CHR Orleans, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fanny Prazuck
1Service des maladies infectieuses, CHR Orleans, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabien Lesne
3Laboratoire de biologie moléculaire, CHR Orleans, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

For the last two years, the SARS-CoV-2 virus spread all around the world and led to the COVID-19 pandemic. The need of methods to control the pandemic and to propose rapid and efficient diagnostic tools has emerged. In this perspective, SARS-CoV-2 rapid antigen detection tests (RADT) have been developed. We performed a retrospective study on 638 collected nasopharyngeal samples used for reference RT-qPCR diagnosis to compare the AQ+ COVID-19 Ag Rapid Test” from InTec (AQ+ InTec test) performance with other commercially available RADT. We analysed the sensitivity and specificity of the different tests and showed a better overall performance of the AQ+ InTec test, which was confirmed on the SARS-Cov-2 Omicron variant. We then conducted a prospective study on 1428 patients, to evaluate the sensitivity and specificity of the AQ+ InTec test on nasal and nasopharyngeal samples in a point of care setting. We showed that sensitivity and specificity reach acceptable criteria regarding the official recommendations of the MDCG 2021-21 in both symptomatic and asymptomatic patients. Overall, the results of these two studies confirm that the AQ+ InTec test is a valuable tool for testing in a pandemic context with a high proportion of asymptomatic patients who are potential carriers for the SARS-CoV-2 virus and is performant on the most current circulating variant Omicron.

Highlights

  • The sensitivity of the AQ+ COVID-19 Ag Rapid Test from InTec reaches 94.4% on nasal samples and 97.4% on nasopharyngeal samples.

  • The performance of the test remains high on asymptomatic patients with a sensitivity of 89.2% on nasal samples and 97.0% on nasopharyngeal samples.

  • Prospective study in a point of care setting revealed a better sensitivity compared with other commercially available rapid antigen detection tests

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

IDRCB2020-A02619-30

Funding Statement

This study was funded by the Regional Hospital of Orleans

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics committee of the Regional Hospital of Orleans (France) and the ethics committee of Sud Ouest and Outre Mer (France) gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • raphael.serreauurc{at}gmail.com

  • aurelie.theillay{at}chr-orleans.fr

  • sandra.pallay{at}chr-orleans.fr

  • daniela-filipa.pires-roteia{at}chr-orleans.fr

  • fanny.prazuck{at}yahoo.fr

  • fabien.lesne{at}chr-orleans.fr

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted September 30, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patients
Thierry Prazuck, Raphael Serreau, Aurelie Theillay, Sandra Pallay, Daniela Pires-Roteia, Fanny Prazuck, Fabien Lesne
medRxiv 2022.09.29.22280448; doi: https://doi.org/10.1101/2022.09.29.22280448
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patients
Thierry Prazuck, Raphael Serreau, Aurelie Theillay, Sandra Pallay, Daniela Pires-Roteia, Fanny Prazuck, Fabien Lesne
medRxiv 2022.09.29.22280448; doi: https://doi.org/10.1101/2022.09.29.22280448

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1094)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9760)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (734)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11636)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1173)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (266)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4649)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (456)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)